Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?

J Nephrol · 2022 · PMC9300572 · PMID 35583597

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Therefore, it is not surprising that the use of RAAS inhibitors in the CKD population after a positive trend from 1999 to 2010 did not increase further in the following decade [ 24 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.